Skip to main content

Contact Noboru Nakaigawa

From: Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab

Contact corresponding author